Paper35656199
Bioengineered Probiotics: Synthetic Biology Can Provide Live Cell Therapeutics for the Treatment of Foodborne Diseases.
Cruz KCP and 2 others. Front Bioeng Biotechnol, 2022. Cited by 20 papers, by iCite.
Cite this record
ConductScience Library. Bioengineered Probiotics: Synthetic Biology Can Provide Live Cell Therapeutics for the Treatment of Foodborne Diseases. Papers, record 35656199. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/35656199
- Sources
- 11 sources
- Release
- papers-2026-11-12-0.1.0
Paper
PubMed's record of the paper, with iCite's citation figures. No abstract is shown.
- Title
- Bioengineered Probiotics: Synthetic Biology Can Provide Live Cell Therapeutics for the Treatment of Foodborne Diseases.
- PubMed
Topics0
NLM's MeSH indexing of the paper, its major topics first.
None in this release.
References193
The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.
| Order | PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|---|
| 1 | 33540694 | Colonisation Factor CD0873, an Attractive Oral Vaccine Candidate against Clostridioides difficile. | Microorganisms | 2021 | https://conductscience.org/library/papers/33540694 | PubMed |
| 2 | 31936328 | Protection Efficacy of Oral Bait Probiotic Vaccine Constitutively Expressing Tetravalent Toxoids against Clostridium perfringens Exotoxins in Livestock (Rabbits). | Vaccines (Basel) | 2020 | https://conductscience.org/library/papers/31936328 | PubMed |
| 3 | 33968585 | Role of probiotics in prevention and treatment of enteric infections: a comprehensive review. | 3 Biotech | 2021 | https://conductscience.org/library/papers/33968585 | PubMed |
| 4 | 32824911 | Selective Eradication of Staphylococcus aureus by the Designer Genetically Programmed Yeast Biocontrol Agent. | Antibiotics (Basel) | 2020 | https://conductscience.org/library/papers/32824911 | PubMed |
| 5 | 23685029 | Evaluation of bacteriophage therapy to control Clostridium difficile and toxin production in an in vitro human colon model system. | Anaerobe | 2013 | https://conductscience.org/library/papers/23685029 | PubMed |
| 6 | 12672861 | Infection with vancomycin-resistant Staphylococcus aureus containing the vanA resistance gene. | N Engl J Med | 2003 | https://conductscience.org/library/papers/12672861 | PubMed |
| 7 | 30687250 | A Novel Bacteriophage Lysin-Human Defensin Fusion Protein Is Effective in Treatment of Clostridioides difficile Infection in Mice. | Front Microbiol | 2018 | https://conductscience.org/library/papers/30687250 | PubMed |
| 8 | 22906361 | Staphylococcal infections: mechanisms of biofilm maturation and detachment as critical determinants of pathogenicity. | Annu Rev Med | 2013 | https://conductscience.org/library/papers/22906361 | PubMed |
| 9 | 30082713 | An update on the human and animal enteric pathogen Clostridium perfringens. | Emerg Microbes Infect | 2018 | https://conductscience.org/library/papers/30082713 | PubMed |
| 10 | 31177350 | Advances in microbial culturing conditions to activate silent biosynthetic gene clusters for novel metabolite production. | J Ind Microbiol Biotechnol | 2019 | https://conductscience.org/library/papers/31177350 | PubMed |
| 11 | 17236612 | Growth promoting antibiotics in food animal production: an economic analysis. | Public Health Rep | 2007 | https://conductscience.org/library/papers/17236612 | PubMed |
| 12 | 32985336 | Bacteriophage endolysins as a potential weapon to combat Clostridioides difficile infection. | Gut Microbes | 2020 | https://conductscience.org/library/papers/32985336 | PubMed |
| 13 | 29524545 | Expression of the alpha toxin of Clostridium perfringens in Lactobacillus casei genome and evaluation of its immune effects in mice. | Microb Pathog | 2018 | https://conductscience.org/library/papers/29524545 | PubMed |
| 14 | 18779344 | Recombinant Bacillus subtilis expressing the Clostridium perfringens alpha toxoid is a candidate orally delivered vaccine against necrotic enteritis. | Infect Immun | 2008 | https://conductscience.org/library/papers/18779344 | PubMed |
| 15 | 34180341 | The Interface of Vibrio cholerae and the Gut Microbiome. | Gut Microbes | 2021 | https://conductscience.org/library/papers/34180341 | PubMed |
| 16 | 32255488 | SER-109, an Investigational Microbiome Drug to Reduce Recurrence After Clostridioides difficile Infection: Lessons Learned From a Phase 2 Trial. | Clin Infect Dis | 2021 | https://conductscience.org/library/papers/32255488 | PubMed |
| 17 | 30238983 | Novel therapies and preventative strategies for primary and recurrent Clostridium difficile infections. | Ann N Y Acad Sci | 2019 | https://conductscience.org/library/papers/30238983 | PubMed |
| 18 | 28676714 | A brief history of antibiotics and select advances in their synthesis. | J Antibiot (Tokyo) | 2018 | https://conductscience.org/library/papers/28676714 | PubMed |
| 19 | 20543037 | Targeted chromosomal knockouts in Mycoplasma pneumoniae. | Appl Environ Microbiol | 2010 | https://conductscience.org/library/papers/20543037 | PubMed |
| 20 | 16728323 | Efficacy of probiotics in prevention of acute diarrhoea: a meta-analysis of masked, randomised, placebo-controlled trials. | Lancet Infect Dis | 2006 | https://conductscience.org/library/papers/16728323 | PubMed |
Cited by15
The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 20 citations.
| PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|
| 42020676 | Gene Exchange Mechanisms in Natural and Engineered Probiotics Within the Human Gut Implications for Antibiotic Resistance and Metabolic Modulation. | Probiotics Antimicrob Proteins | 2026 | https://conductscience.org/library/papers/42020676 | PubMed |
| 41975425 | From lab to law: emerging applications, potential benefits, evolving regulatory framework and challenges for engineered probiotics. | Microb Cell Fact | 2026 | https://conductscience.org/library/papers/41975425 | PubMed |
| 41882398 | Microbial Biotechnology in Medicine. | Prog Mol Subcell Biol | 2026 | https://conductscience.org/library/papers/41882398 | PubMed |
| 41877779 | The gut microbiome in colorectal anastomotic leakage: from mechanisms to precision. | Front Med (Lausanne) | 2026 | https://conductscience.org/library/papers/41877779 | PubMed |
| 41823362 | Precision Microbial Therapeutics for Infertility: Next-Generation Probiotics, Engineered Biologics and Translational Pathways. | Microb Biotechnol | 2026 | https://conductscience.org/library/papers/41823362 | PubMed |
| 41505076 | Designing the Next Generation of Endolysins: A Triple Strategy Integrating Bioinformatics Mining, Engineering Modification and Encapsulation Formulation. | Probiotics Antimicrob Proteins | 2026 | https://conductscience.org/library/papers/41505076 | PubMed |
| 41438195 | Study to evaluate the safety and tolerability of Streptococcus salivarius eK12, a genetically modified strain derived from the oral probiotic S. salivarius K12: Results from a randomized, double-blind, placebo-controlled, parallel-group clinical trial. | Front Nutr | 2025 | https://conductscience.org/library/papers/41438195 | PubMed |
| 39877756 | Water pollution, cholera, and the role of probiotics: a comprehensive review in relation to public health in Bangladesh. | Front Microbiol | 2024 | https://conductscience.org/library/papers/39877756 | PubMed |
| 39597673 | Assessment of Biofilm Formation and Anti-Inflammatory Response of a Probiotic Blend in a Cultured Canine Cell Model. | Microorganisms | 2024 | https://conductscience.org/library/papers/39597673 | PubMed |
| 39588716 | Next-Generation Probiotics and Chronic Diseases: A Review of Current Research and Future Directions. | J Agric Food Chem | 2024 | https://conductscience.org/library/papers/39588716 | PubMed |
| 39531149 | Bioengineered Probiotics for Clostridioides difficile Infection: An Overview of the Challenges and Potential for This New Treatment Approach. | Probiotics Antimicrob Proteins | 2025 | https://conductscience.org/library/papers/39531149 | PubMed |
| 39392836 | Microbes as medicine. | Ann N Y Acad Sci | 2024 | https://conductscience.org/library/papers/39392836 | PubMed |
| 39106212 | Phage lysins for intestinal microbiome modulation: current challenges and enabling techniques. | Gut Microbes | 2024 | https://conductscience.org/library/papers/39106212 | PubMed |
| 37309041 | Engineered Bacillus subtilis alleviates intestinal oxidative injury through Nrf2-Keap1 pathway in enterotoxigenic Escherichia coli (ETEC) K88-infected piglet. | J Zhejiang Univ Sci B | 2023 | https://conductscience.org/library/papers/37309041 | PubMed |
| 37106999 | About Functional Foods: The Probiotics and Prebiotics State of Art. | Antibiotics (Basel) | 2023 | https://conductscience.org/library/papers/37106999 | PubMed |
Data dates
The date of each source this release read.
- Trials
- 2026-11-12
- Gene search
- 2026-11-11
- Pipelines
- 2026-09-18
None in this release
- Grants
- Trials
- Comments and corrections
- Genes
- Drugs
- Data
Sources 11
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- HGNCCC0
- iCiteCC BY 4.0
- NCBI GenePublic domain (US government)
- NIH RePORTER's grant and paper linksPublic domain
- Open TargetsCC0 1.0
- PMC's ID filePublic domain (US government)
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- HGNCCC0: https://www.genenames.org/about/license/
- iCiteCC BY 4.0
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this paper from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/papers/v1/35656199
GET https://conductscience.org/api/papers/v1/35656199/references?page=2